Graftless Technique in Open Maxillary Sinus Lifting Using PEEK Versus Ti -Meshwork

February 20, 2025 updated by: mohamed gamal hammad, Cairo University

Graftless Technique in Open Maxillary Sinus Lifting Using Poly-Ether-Ether-Ketone Versus Titanium Meshwork for Evaluation of Bone Quantity: Randomized Clinical Trials

The aim of the study is to assess the amount of bone formation with PEEK (intervention group) in comparison with Titanium Meshwork (control group) in maxillary sinus lifting using CBCT and assessment of the biocompatibility of the Meshwork and PEEK with the schniederian membrane integrity.

Study Overview

Status

Completed

Conditions

Detailed Description

All patients involved in this study will be divided into two equal groups, each group will be; (Tested group): PEEK after maxillary sinus lifts (Caldwell luc approach). (Control group): Titanium meshwork after maxillary sinus lifts (Caldwell luc approach).

Clinical evaluation:

A through medical and dental history followed by clinical examination was carried out for all patients. Clinical measurements were taken to ensure patient adherence to our initial inclusion criteria prior to further investigations.

A preoperative digital panoramic radiograph with 1:1 magnification was taken for each patient as a primary survey in order to exclude the presence of any lesion at the area of interest and take a primary measurement for the residual bone height of maxillary sinus.

CBCT will be taken in order to design the custom-made PEEK model and its guide of external window before the milling.

Intra operative procedures for two groups:

The operation was carried out with the patient under local anesthesia (2% Lido HCl with 1:100,000 epinephrine). The perioral areas were aseptically prepared. A crestal incision was made on the midline of the gingiva attached to the edentulous ridge. The flap was elevated carefully and extended labially to expose the bone. A mesial and distal vertical releasing incision will be made as needed. The mucosal flap was denuded subperiosteally to fully expose the sharp and thin alveolar ridge and the lateral wall of the maxillary sinus. Extreme care was taken to radically elevate the sinus membrane from the lateral access window opened by using an electric-motor drill with appropriate water cooling. The floor, lateral wall, medial and posterior wall of the sinus membrane were meticulously detached and pushed upward for the placement of PEEK in intervention group and titanium meshwork in control group.

• Follow up: Patients will be evaluated after 3 days and weekly for the first month and then after 6 months Radiographic assessment will be achieved by CBCT scan 6 months postoperatively to calculate the amount of vertical bone gain.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 14444
        • Faculty of Dentistry Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • • Posterior edentulous ridges with pneumatized maxillary sinus and remaining bone height of 3 to 6 mm.

    • Patient age ranges from 25 to 50 years.
    • ASA physical status I and II.
    • Patients willing to be a part of the study and ready to give their consent in writing for the same.
    • Patient not complains from maxillary sinusitis
    • Patients are free from T.M.J disorders, abnormal oral habits such as bruxism.
    • Patient with good oral hygiene.

Exclusion Criteria:

  • • Untreated gingivitis, periodontitis.

    • Subjected to irradiation in the head and neck area less than 1 year before implantation.
    • Untreated periodontitis.
    • Insufficient oral hygiene and motivation.
    • Pregnant or nursing.
    • Bone pathology.
    • Patient with blood disease.
    • Patient with any systematic disease that may affect normal healing.
    • Active infection or severe inflammation in the area intended for implant placement.
    • Treated or under treatment with intravenous amino-bisphosphonates.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: placement of titanium meshwork after maxillary sinus lifting
placement of titanium meshwork after maxillary sinus lifting
Experimental: placement of PEEK after maxillary sinus lifting
placement of PEEK after maxillary sinus lifting
Other Names:
  • poly ether ether ketone

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bone quantity
Time Frame: at 6 months of maxillary sinus lifting
assessment of bone quantity using CBCT
at 6 months of maxillary sinus lifting

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compatibility with Schneiderian membrane
Time Frame: at 6 months of maxillary sinus lifting
assessment of the biocompatibility with Schneiderian membrane
at 6 months of maxillary sinus lifting

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 3, 2024

Primary Completion (Actual)

October 3, 2024

Study Completion (Actual)

November 3, 2024

Study Registration Dates

First Submitted

February 16, 2025

First Submitted That Met QC Criteria

February 20, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 20, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Maxillary Sinus

Clinical Trials on titanium meshwork

Subscribe